2022 |
Hypoxia-induced inhibin promotes tumor growth and vascular permeability in ovarian cancers. |
Nam Lee, Ph.D. |
2022 |
Cutaneous heat and light-induced pain thresholds in post-traumatic headache attributed to mild traumatic brain injury. |
Frank Porreca, PhD |
2022 |
Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancer. |
Nam Lee, Ph.D. |
2022 |
Transport Mechanisms at the Blood-Brain Barrier and in Cellular Compartments of the Neurovascular Unit: Focus on CNS Delivery of Small Molecule Drugs. |
Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS |
2022 |
Extracellular Alterations in pH and K+ Modify the Murine Brain Endothelial Cell Total and Phospho-Proteome. |
Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, John M. Streicher, PhD, Todd Vanderah, PhD |
2022 |
Age-Induced Changes in μ-Opioid Receptor Signaling in the Midbrain Periaqueductal Gray of Male and Female Rats. |
John M. Streicher, PhD |
2022 |
Androgen-targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer. |
Roberta Diaz Brinton, Ph.D, Kathleen Rodgers, Ph.D. |
2022 |
Regulation of Blood-Brain Barrier Transporters by Transforming Growth Factor-/Activin Receptor-Like Kinase 1 Signaling: Relevance to the Brain Disposition of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors (i.e., Statins). |
Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD, Patrick T Ronaldson, PhD, FAAPS |
2022 |
Synthesis of ()()-Tiruchanduramine. |
Christopher Cartmell |
2022 |
Blood-Brain Barrier Transporters: Opportunities for Therapeutic Development in Ischemic Stroke. |
Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS |
2022 |
A tale of two systems: Lessons learned from female mid-life aging with implications for Alzheimer's prevention & treatment. |
Roberta Diaz Brinton, Ph.D, Kathleen Rodgers, Ph.D., Fei Yin, Ph.D. |
2022 |
Radiocaine: An Imaging Marker of Neuropathic Injury. |
Tally Largent-Milnes, PhD |
2022 |
Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraine. |
Edita Navratilova, Frank Porreca, PhD |
2022 |
Inhibition of HSP90 Preserves Blood-Brain Barrier Integrity after Cortical Spreading Depression. |
Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, John M. Streicher, PhD |
2022 |
High-Dose Acetaminophen Alters the Integrity of the Blood-Brain Barrier and Leads to Increased CNS Uptake of Codeine in Rats. |
Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD, Patrick T Ronaldson, PhD, FAAPS |
2022 |
Microencapsulation and incubation methodology for the cultivation of marine bacteria. |
Christopher Cartmell |
2022 |
Angiotensin-(1-7) improves cognitive function and reduces inflammation in mice following mild traumatic brain injury. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
2022 |
Association Between Specific Type 2 Diabetes Therapies and Risk of Alzheimer's Disease and Related Dementias in Propensity-Score Matched Type 2 Diabetic Patients. |
Roberta Diaz Brinton, Ph.D, Kathleen Rodgers, Ph.D. |
2022 |
Editorial: Chronic orofacial pain. |
Frank Porreca, PhD |
2022 |
Effects of docosahexaenoic acid and eicosapentaoic acid supplementation on white matter integrity after repetitive sub-concussive head impacts during American football: Exploratory neuroimaging findings from a pilot RCT. |
Roberta Diaz Brinton, Ph.D |
2022 |
Kappa Opioid Receptor Blockade in the Amygdala Mitigates Pain Like-Behaviors by Inhibiting Corticotropin Releasing Factor Neurons in a Rat Model of Functional Pain. |
Edita Navratilova, Frank Porreca, PhD |
2021 |
Decreased dopaminergic inhibition of pyramidal neurons in anterior cingulate cortex maintains chronic neuropathic pain. |
Edita Navratilova, Frank Porreca, PhD |
2021 |
High-fiber diet mitigates maternal obesity-induced cognitive and social dysfunction in the offspring via gut-brain axis. |
Fei Yin, Ph.D. |
2021 |
Methionine restriction alleviates age-associated cognitive decline via fibroblast growth factor 21. |
Fei Yin, Ph.D. |
2021 |
Mitochondria-Targeted Therapeutics for Alzheimer's Disease: The Good, the Bad, the Potential. |
Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D. |